Vontobel Holding Ltd. Ocular Therapeutix, Inc Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jun 03, 2024	SELL	$4.6 - $7.64 $69,000 - $114,600	-15,000 Reduced 60.0%	10,000 $51,000
Q2 2023 Jul 24, 2023	SELL	$4.6 - $7.64 $69,000 - $114,600	-15,000 Reduced 60.0%	10,000 $51,000
Q1 2023 Jun 03, 2024	BUY	$2.79 - $6.27 $69,750 - $156,750	25,000 New	25,000 $131,000
Q1 2023 Apr 12, 2023	BUY	$2.79 - $6.27 $2,790 - $6,270	1,000 Added 4.17%	25,000 $131,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $62,640 - $105,840	24,000 New	24,000 $67,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.